Drugs / SP0202-IIb
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04583618 | Oct 2020 → Aug 2021 | — | Sanofi | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SP0202-IIb | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04583618 ↗ |
| Modality | Vaccine | “Pneumococcal Conjugate Vaccine” NCT04583618 ↗ |
| Route | Intramuscular | “Route of administration: intramuscular” NCT04583618 ↗ |